Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
14.11
-0.53 (-3.62%)
At close: Aug 31, 2026, 4:00 PM EDT
14.01
-0.10 (-0.71%)
After-hours: Aug 31, 2026, 7:39 PM EDT

Alpha Tau Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Alpha Tau Medical stock has a consensus rating of "Buy" and an average price target of $14.4. The average 1-year stock price forecast is 2.06% higher than the current stock price, while the lowest is $8.00 (-43.30%) and the highest is $17 (+20.48%).

Price Target: $14.4 (+2.06%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$8.00$14.4$16$17
Change-43.30%+2.06%+13.39%+20.48%

Analyst Ratings

The average analyst rating for Alpha Tau Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy333333
Buy001111
Hold111111
Sell000000
Strong Sell000000
Total445555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$15$16
BuyReiterates$15$16+13.39%Aug 11, 2026
Piper Sandler
Piper Sandler
Hold
Reiterates
$8
HoldReiterates$8-43.30%Aug 11, 2026
Barclays
Barclays
Buy
Maintains
$17
BuyMaintains$17+20.48%Aug 11, 2026
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
Buy
Reiterates
$14
BuyReiterates$14-0.78%May 12, 2026
Citi
Citi
Buy
Reiterates
$7$9
BuyReiterates$7$9-36.22%Mar 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
2.26M
Revenue Next Year
16.51M
from 2.26M
Increased by 630.19%
EPS This Year
-0.88
from -0.53
EPS Next Year
-0.53
from -0.88
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-----2.26M
Operating Income
-13.79M-32.14M-35.68M-36.04M-42.29M-54.88M
EPS
-----0.53-0.88
Free Cash Flow
-7.53M-14.62M-19.40M-12.97M-19.70M-95.00M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.2M
Avg2.3M
Low1.3M

Revenue Growth

Revenue Growth20272028
High
1,200.0%
Avg
630.2%
Low
234.3%

EPS Forecast

EPS202620272028
High-0.55
Avg-0.88
Low-1.08

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-